Global Cardiac Disease Stem Cell Therapy Market Growth (Status and Outlook) 2026-2032
The global Cardiac Disease Stem Cell Therapy market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
United States market for Cardiac Disease Stem Cell Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Cardiac Disease Stem Cell Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Cardiac Disease Stem Cell Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Cardiac Disease Stem Cell Therapy players cover Pharmicell, Gencell, BlueRock Therapeutics, Cellino Biotech, Mesoblast, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?Cardiac Disease Stem Cell Therapy Industry Forecast? looks at past sales and reviews total world Cardiac Disease Stem Cell Therapy sales in 2025, providing a comprehensive analysis by region and market sector of projected Cardiac Disease Stem Cell Therapy sales for 2026 through 2032. With Cardiac Disease Stem Cell Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cardiac Disease Stem Cell Therapy industry.
This Insight Report provides a comprehensive analysis of the global Cardiac Disease Stem Cell Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cardiac Disease Stem Cell Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Cardiac Disease Stem Cell Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cardiac Disease Stem Cell Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cardiac Disease Stem Cell Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Cardiac Disease Stem Cell Therapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
United States market for Cardiac Disease Stem Cell Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Cardiac Disease Stem Cell Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Cardiac Disease Stem Cell Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Cardiac Disease Stem Cell Therapy players cover Pharmicell, Gencell, BlueRock Therapeutics, Cellino Biotech, Mesoblast, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?Cardiac Disease Stem Cell Therapy Industry Forecast? looks at past sales and reviews total world Cardiac Disease Stem Cell Therapy sales in 2025, providing a comprehensive analysis by region and market sector of projected Cardiac Disease Stem Cell Therapy sales for 2026 through 2032. With Cardiac Disease Stem Cell Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cardiac Disease Stem Cell Therapy industry.
This Insight Report provides a comprehensive analysis of the global Cardiac Disease Stem Cell Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cardiac Disease Stem Cell Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Cardiac Disease Stem Cell Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cardiac Disease Stem Cell Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cardiac Disease Stem Cell Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Cardiac Disease Stem Cell Therapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Autologous
- Allogeneic
- Preclinical
- Clinical Phase 1,2
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pharmicell
- Gencell
- BlueRock Therapeutics
- Cellino Biotech
- Mesoblast
- BioCardia
- Cedars-Sinai
- Stem Cells Transplant Institute
- CCTRN
- Help Therapeutics Co., Ltd.
- Beijing Cellapy biotechnology Co., LTD
- CardioCell
- Heartseed
- EmCell
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cardiac Disease Stem Cell Therapy Market Size (2021-2032)
2.1.2 Cardiac Disease Stem Cell Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Cardiac Disease Stem Cell Therapy by Country/Region (2021, 2025 & 2032)
2.2 Cardiac Disease Stem Cell Therapy Segment by Type
2.2.1 Autologous
2.2.2 Allogeneic
2.2.3 Cardiac Disease Stem Cell Therapy Market Size by Type
2.2.3.1 Cardiac Disease Stem Cell Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Cardiac Disease Stem Cell Therapy Market Size Market Share by Type (2021-2026)
2.3 Cardiac Disease Stem Cell Therapy Segment by Application
2.3.1 Preclinical
2.3.2 Clinical Phase 1,2
2.3.3 Cardiac Disease Stem Cell Therapy Market Size by Application
2.3.3.1 Cardiac Disease Stem Cell Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global Cardiac Disease Stem Cell Therapy Market Size Market Share by Application (2021-2026)
3 CARDIAC DISEASE STEM CELL THERAPY MARKET SIZE BY PLAYER
3.1 Cardiac Disease Stem Cell Therapy Market Size Market Share by Player
3.1.1 Global Cardiac Disease Stem Cell Therapy Revenue by Player (2021-2026)
3.1.2 Global Cardiac Disease Stem Cell Therapy Revenue Market Share by Player (2021-2026)
3.2 Global Cardiac Disease Stem Cell Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CARDIAC DISEASE STEM CELL THERAPY BY REGION
4.1 Cardiac Disease Stem Cell Therapy Market Size by Region (2021-2026)
4.2 Global Cardiac Disease Stem Cell Therapy Annual Revenue by Country/Region (2021-2026)
4.3 Americas Cardiac Disease Stem Cell Therapy Market Size Growth (2021-2026)
4.4 APAC Cardiac Disease Stem Cell Therapy Market Size Growth (2021-2026)
4.5 Europe Cardiac Disease Stem Cell Therapy Market Size Growth (2021-2026)
4.6 Middle East & Africa Cardiac Disease Stem Cell Therapy Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Cardiac Disease Stem Cell Therapy Market Size by Country (2021-2026)
5.2 Americas Cardiac Disease Stem Cell Therapy Market Size by Type (2021-2026)
5.3 Americas Cardiac Disease Stem Cell Therapy Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cardiac Disease Stem Cell Therapy Market Size by Region (2021-2026)
6.2 APAC Cardiac Disease Stem Cell Therapy Market Size by Type (2021-2026)
6.3 APAC Cardiac Disease Stem Cell Therapy Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cardiac Disease Stem Cell Therapy Market Size by Country (2021-2026)
7.2 Europe Cardiac Disease Stem Cell Therapy Market Size by Type (2021-2026)
7.3 Europe Cardiac Disease Stem Cell Therapy Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cardiac Disease Stem Cell Therapy by Region (2021-2026)
8.2 Middle East & Africa Cardiac Disease Stem Cell Therapy Market Size by Type (2021-2026)
8.3 Middle East & Africa Cardiac Disease Stem Cell Therapy Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CARDIAC DISEASE STEM CELL THERAPY MARKET FORECAST
10.1 Global Cardiac Disease Stem Cell Therapy Forecast by Region (2027-2032)
10.1.1 Global Cardiac Disease Stem Cell Therapy Forecast by Region (2027-2032)
10.1.2 Americas Cardiac Disease Stem Cell Therapy Forecast
10.1.3 APAC Cardiac Disease Stem Cell Therapy Forecast
10.1.4 Europe Cardiac Disease Stem Cell Therapy Forecast
10.1.5 Middle East & Africa Cardiac Disease Stem Cell Therapy Forecast
10.2 Americas Cardiac Disease Stem Cell Therapy Forecast by Country (2027-2032)
10.2.1 United States Market Cardiac Disease Stem Cell Therapy Forecast
10.2.2 Canada Market Cardiac Disease Stem Cell Therapy Forecast
10.2.3 Mexico Market Cardiac Disease Stem Cell Therapy Forecast
10.2.4 Brazil Market Cardiac Disease Stem Cell Therapy Forecast
10.3 APAC Cardiac Disease Stem Cell Therapy Forecast by Region (2027-2032)
10.3.1 China Cardiac Disease Stem Cell Therapy Market Forecast
10.3.2 Japan Market Cardiac Disease Stem Cell Therapy Forecast
10.3.3 Korea Market Cardiac Disease Stem Cell Therapy Forecast
10.3.4 Southeast Asia Market Cardiac Disease Stem Cell Therapy Forecast
10.3.5 India Market Cardiac Disease Stem Cell Therapy Forecast
10.3.6 Australia Market Cardiac Disease Stem Cell Therapy Forecast
10.4 Europe Cardiac Disease Stem Cell Therapy Forecast by Country (2027-2032)
10.4.1 Germany Market Cardiac Disease Stem Cell Therapy Forecast
10.4.2 France Market Cardiac Disease Stem Cell Therapy Forecast
10.4.3 UK Market Cardiac Disease Stem Cell Therapy Forecast
10.4.4 Italy Market Cardiac Disease Stem Cell Therapy Forecast
10.4.5 Russia Market Cardiac Disease Stem Cell Therapy Forecast
10.5 Middle East & Africa Cardiac Disease Stem Cell Therapy Forecast by Region (2027-2032)
10.5.1 Egypt Market Cardiac Disease Stem Cell Therapy Forecast
10.5.2 South Africa Market Cardiac Disease Stem Cell Therapy Forecast
10.5.3 Israel Market Cardiac Disease Stem Cell Therapy Forecast
10.5.4 Turkey Market Cardiac Disease Stem Cell Therapy Forecast
10.6 Global Cardiac Disease Stem Cell Therapy Forecast by Type (2027-2032)
10.7 Global Cardiac Disease Stem Cell Therapy Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Cardiac Disease Stem Cell Therapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 Pharmicell
11.1.1 Pharmicell Company Information
11.1.2 Pharmicell Cardiac Disease Stem Cell Therapy Product Offered
11.1.3 Pharmicell Cardiac Disease Stem Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Pharmicell Main Business Overview
11.1.5 Pharmicell Latest Developments
11.2 Gencell
11.2.1 Gencell Company Information
11.2.2 Gencell Cardiac Disease Stem Cell Therapy Product Offered
11.2.3 Gencell Cardiac Disease Stem Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Gencell Main Business Overview
11.2.5 Gencell Latest Developments
11.3 BlueRock Therapeutics
11.3.1 BlueRock Therapeutics Company Information
11.3.2 BlueRock Therapeutics Cardiac Disease Stem Cell Therapy Product Offered
11.3.3 BlueRock Therapeutics Cardiac Disease Stem Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 BlueRock Therapeutics Main Business Overview
11.3.5 BlueRock Therapeutics Latest Developments
11.4 Cellino Biotech
11.4.1 Cellino Biotech Company Information
11.4.2 Cellino Biotech Cardiac Disease Stem Cell Therapy Product Offered
11.4.3 Cellino Biotech Cardiac Disease Stem Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Cellino Biotech Main Business Overview
11.4.5 Cellino Biotech Latest Developments
11.5 Mesoblast
11.5.1 Mesoblast Company Information
11.5.2 Mesoblast Cardiac Disease Stem Cell Therapy Product Offered
11.5.3 Mesoblast Cardiac Disease Stem Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Mesoblast Main Business Overview
11.5.5 Mesoblast Latest Developments
11.6 BioCardia
11.6.1 BioCardia Company Information
11.6.2 BioCardia Cardiac Disease Stem Cell Therapy Product Offered
11.6.3 BioCardia Cardiac Disease Stem Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 BioCardia Main Business Overview
11.6.5 BioCardia Latest Developments
11.7 Cedars-Sinai
11.7.1 Cedars-Sinai Company Information
11.7.2 Cedars-Sinai Cardiac Disease Stem Cell Therapy Product Offered
11.7.3 Cedars-Sinai Cardiac Disease Stem Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Cedars-Sinai Main Business Overview
11.7.5 Cedars-Sinai Latest Developments
11.8 Stem Cells Transplant Institute
11.8.1 Stem Cells Transplant Institute Company Information
11.8.2 Stem Cells Transplant Institute Cardiac Disease Stem Cell Therapy Product Offered
11.8.3 Stem Cells Transplant Institute Cardiac Disease Stem Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Stem Cells Transplant Institute Main Business Overview
11.8.5 Stem Cells Transplant Institute Latest Developments
11.9 CCTRN
11.9.1 CCTRN Company Information
11.9.2 CCTRN Cardiac Disease Stem Cell Therapy Product Offered
11.9.3 CCTRN Cardiac Disease Stem Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 CCTRN Main Business Overview
11.9.5 CCTRN Latest Developments
11.10 Help Therapeutics Co., Ltd.
11.10.1 Help Therapeutics Co., Ltd. Company Information
11.10.2 Help Therapeutics Co., Ltd. Cardiac Disease Stem Cell Therapy Product Offered
11.10.3 Help Therapeutics Co., Ltd. Cardiac Disease Stem Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Help Therapeutics Co., Ltd. Main Business Overview
11.10.5 Help Therapeutics Co., Ltd. Latest Developments
11.11 Beijing Cellapy biotechnology Co., LTD
11.11.1 Beijing Cellapy biotechnology Co., LTD Company Information
11.11.2 Beijing Cellapy biotechnology Co., LTD Cardiac Disease Stem Cell Therapy Product Offered
11.11.3 Beijing Cellapy biotechnology Co., LTD Cardiac Disease Stem Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Beijing Cellapy biotechnology Co., LTD Main Business Overview
11.11.5 Beijing Cellapy biotechnology Co., LTD Latest Developments
11.12 CardioCell
11.12.1 CardioCell Company Information
11.12.2 CardioCell Cardiac Disease Stem Cell Therapy Product Offered
11.12.3 CardioCell Cardiac Disease Stem Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 CardioCell Main Business Overview
11.12.5 CardioCell Latest Developments
11.13 Heartseed
11.13.1 Heartseed Company Information
11.13.2 Heartseed Cardiac Disease Stem Cell Therapy Product Offered
11.13.3 Heartseed Cardiac Disease Stem Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Heartseed Main Business Overview
11.13.5 Heartseed Latest Developments
11.14 EmCell
11.14.1 EmCell Company Information
11.14.2 EmCell Cardiac Disease Stem Cell Therapy Product Offered
11.14.3 EmCell Cardiac Disease Stem Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 EmCell Main Business Overview
11.14.5 EmCell Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cardiac Disease Stem Cell Therapy Market Size (2021-2032)
2.1.2 Cardiac Disease Stem Cell Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Cardiac Disease Stem Cell Therapy by Country/Region (2021, 2025 & 2032)
2.2 Cardiac Disease Stem Cell Therapy Segment by Type
2.2.1 Autologous
2.2.2 Allogeneic
2.2.3 Cardiac Disease Stem Cell Therapy Market Size by Type
2.2.3.1 Cardiac Disease Stem Cell Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Cardiac Disease Stem Cell Therapy Market Size Market Share by Type (2021-2026)
2.3 Cardiac Disease Stem Cell Therapy Segment by Application
2.3.1 Preclinical
2.3.2 Clinical Phase 1,2
2.3.3 Cardiac Disease Stem Cell Therapy Market Size by Application
2.3.3.1 Cardiac Disease Stem Cell Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global Cardiac Disease Stem Cell Therapy Market Size Market Share by Application (2021-2026)
3 CARDIAC DISEASE STEM CELL THERAPY MARKET SIZE BY PLAYER
3.1 Cardiac Disease Stem Cell Therapy Market Size Market Share by Player
3.1.1 Global Cardiac Disease Stem Cell Therapy Revenue by Player (2021-2026)
3.1.2 Global Cardiac Disease Stem Cell Therapy Revenue Market Share by Player (2021-2026)
3.2 Global Cardiac Disease Stem Cell Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CARDIAC DISEASE STEM CELL THERAPY BY REGION
4.1 Cardiac Disease Stem Cell Therapy Market Size by Region (2021-2026)
4.2 Global Cardiac Disease Stem Cell Therapy Annual Revenue by Country/Region (2021-2026)
4.3 Americas Cardiac Disease Stem Cell Therapy Market Size Growth (2021-2026)
4.4 APAC Cardiac Disease Stem Cell Therapy Market Size Growth (2021-2026)
4.5 Europe Cardiac Disease Stem Cell Therapy Market Size Growth (2021-2026)
4.6 Middle East & Africa Cardiac Disease Stem Cell Therapy Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Cardiac Disease Stem Cell Therapy Market Size by Country (2021-2026)
5.2 Americas Cardiac Disease Stem Cell Therapy Market Size by Type (2021-2026)
5.3 Americas Cardiac Disease Stem Cell Therapy Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cardiac Disease Stem Cell Therapy Market Size by Region (2021-2026)
6.2 APAC Cardiac Disease Stem Cell Therapy Market Size by Type (2021-2026)
6.3 APAC Cardiac Disease Stem Cell Therapy Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cardiac Disease Stem Cell Therapy Market Size by Country (2021-2026)
7.2 Europe Cardiac Disease Stem Cell Therapy Market Size by Type (2021-2026)
7.3 Europe Cardiac Disease Stem Cell Therapy Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cardiac Disease Stem Cell Therapy by Region (2021-2026)
8.2 Middle East & Africa Cardiac Disease Stem Cell Therapy Market Size by Type (2021-2026)
8.3 Middle East & Africa Cardiac Disease Stem Cell Therapy Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CARDIAC DISEASE STEM CELL THERAPY MARKET FORECAST
10.1 Global Cardiac Disease Stem Cell Therapy Forecast by Region (2027-2032)
10.1.1 Global Cardiac Disease Stem Cell Therapy Forecast by Region (2027-2032)
10.1.2 Americas Cardiac Disease Stem Cell Therapy Forecast
10.1.3 APAC Cardiac Disease Stem Cell Therapy Forecast
10.1.4 Europe Cardiac Disease Stem Cell Therapy Forecast
10.1.5 Middle East & Africa Cardiac Disease Stem Cell Therapy Forecast
10.2 Americas Cardiac Disease Stem Cell Therapy Forecast by Country (2027-2032)
10.2.1 United States Market Cardiac Disease Stem Cell Therapy Forecast
10.2.2 Canada Market Cardiac Disease Stem Cell Therapy Forecast
10.2.3 Mexico Market Cardiac Disease Stem Cell Therapy Forecast
10.2.4 Brazil Market Cardiac Disease Stem Cell Therapy Forecast
10.3 APAC Cardiac Disease Stem Cell Therapy Forecast by Region (2027-2032)
10.3.1 China Cardiac Disease Stem Cell Therapy Market Forecast
10.3.2 Japan Market Cardiac Disease Stem Cell Therapy Forecast
10.3.3 Korea Market Cardiac Disease Stem Cell Therapy Forecast
10.3.4 Southeast Asia Market Cardiac Disease Stem Cell Therapy Forecast
10.3.5 India Market Cardiac Disease Stem Cell Therapy Forecast
10.3.6 Australia Market Cardiac Disease Stem Cell Therapy Forecast
10.4 Europe Cardiac Disease Stem Cell Therapy Forecast by Country (2027-2032)
10.4.1 Germany Market Cardiac Disease Stem Cell Therapy Forecast
10.4.2 France Market Cardiac Disease Stem Cell Therapy Forecast
10.4.3 UK Market Cardiac Disease Stem Cell Therapy Forecast
10.4.4 Italy Market Cardiac Disease Stem Cell Therapy Forecast
10.4.5 Russia Market Cardiac Disease Stem Cell Therapy Forecast
10.5 Middle East & Africa Cardiac Disease Stem Cell Therapy Forecast by Region (2027-2032)
10.5.1 Egypt Market Cardiac Disease Stem Cell Therapy Forecast
10.5.2 South Africa Market Cardiac Disease Stem Cell Therapy Forecast
10.5.3 Israel Market Cardiac Disease Stem Cell Therapy Forecast
10.5.4 Turkey Market Cardiac Disease Stem Cell Therapy Forecast
10.6 Global Cardiac Disease Stem Cell Therapy Forecast by Type (2027-2032)
10.7 Global Cardiac Disease Stem Cell Therapy Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Cardiac Disease Stem Cell Therapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 Pharmicell
11.1.1 Pharmicell Company Information
11.1.2 Pharmicell Cardiac Disease Stem Cell Therapy Product Offered
11.1.3 Pharmicell Cardiac Disease Stem Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Pharmicell Main Business Overview
11.1.5 Pharmicell Latest Developments
11.2 Gencell
11.2.1 Gencell Company Information
11.2.2 Gencell Cardiac Disease Stem Cell Therapy Product Offered
11.2.3 Gencell Cardiac Disease Stem Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Gencell Main Business Overview
11.2.5 Gencell Latest Developments
11.3 BlueRock Therapeutics
11.3.1 BlueRock Therapeutics Company Information
11.3.2 BlueRock Therapeutics Cardiac Disease Stem Cell Therapy Product Offered
11.3.3 BlueRock Therapeutics Cardiac Disease Stem Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 BlueRock Therapeutics Main Business Overview
11.3.5 BlueRock Therapeutics Latest Developments
11.4 Cellino Biotech
11.4.1 Cellino Biotech Company Information
11.4.2 Cellino Biotech Cardiac Disease Stem Cell Therapy Product Offered
11.4.3 Cellino Biotech Cardiac Disease Stem Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Cellino Biotech Main Business Overview
11.4.5 Cellino Biotech Latest Developments
11.5 Mesoblast
11.5.1 Mesoblast Company Information
11.5.2 Mesoblast Cardiac Disease Stem Cell Therapy Product Offered
11.5.3 Mesoblast Cardiac Disease Stem Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Mesoblast Main Business Overview
11.5.5 Mesoblast Latest Developments
11.6 BioCardia
11.6.1 BioCardia Company Information
11.6.2 BioCardia Cardiac Disease Stem Cell Therapy Product Offered
11.6.3 BioCardia Cardiac Disease Stem Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 BioCardia Main Business Overview
11.6.5 BioCardia Latest Developments
11.7 Cedars-Sinai
11.7.1 Cedars-Sinai Company Information
11.7.2 Cedars-Sinai Cardiac Disease Stem Cell Therapy Product Offered
11.7.3 Cedars-Sinai Cardiac Disease Stem Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Cedars-Sinai Main Business Overview
11.7.5 Cedars-Sinai Latest Developments
11.8 Stem Cells Transplant Institute
11.8.1 Stem Cells Transplant Institute Company Information
11.8.2 Stem Cells Transplant Institute Cardiac Disease Stem Cell Therapy Product Offered
11.8.3 Stem Cells Transplant Institute Cardiac Disease Stem Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Stem Cells Transplant Institute Main Business Overview
11.8.5 Stem Cells Transplant Institute Latest Developments
11.9 CCTRN
11.9.1 CCTRN Company Information
11.9.2 CCTRN Cardiac Disease Stem Cell Therapy Product Offered
11.9.3 CCTRN Cardiac Disease Stem Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 CCTRN Main Business Overview
11.9.5 CCTRN Latest Developments
11.10 Help Therapeutics Co., Ltd.
11.10.1 Help Therapeutics Co., Ltd. Company Information
11.10.2 Help Therapeutics Co., Ltd. Cardiac Disease Stem Cell Therapy Product Offered
11.10.3 Help Therapeutics Co., Ltd. Cardiac Disease Stem Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Help Therapeutics Co., Ltd. Main Business Overview
11.10.5 Help Therapeutics Co., Ltd. Latest Developments
11.11 Beijing Cellapy biotechnology Co., LTD
11.11.1 Beijing Cellapy biotechnology Co., LTD Company Information
11.11.2 Beijing Cellapy biotechnology Co., LTD Cardiac Disease Stem Cell Therapy Product Offered
11.11.3 Beijing Cellapy biotechnology Co., LTD Cardiac Disease Stem Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Beijing Cellapy biotechnology Co., LTD Main Business Overview
11.11.5 Beijing Cellapy biotechnology Co., LTD Latest Developments
11.12 CardioCell
11.12.1 CardioCell Company Information
11.12.2 CardioCell Cardiac Disease Stem Cell Therapy Product Offered
11.12.3 CardioCell Cardiac Disease Stem Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 CardioCell Main Business Overview
11.12.5 CardioCell Latest Developments
11.13 Heartseed
11.13.1 Heartseed Company Information
11.13.2 Heartseed Cardiac Disease Stem Cell Therapy Product Offered
11.13.3 Heartseed Cardiac Disease Stem Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Heartseed Main Business Overview
11.13.5 Heartseed Latest Developments
11.14 EmCell
11.14.1 EmCell Company Information
11.14.2 EmCell Cardiac Disease Stem Cell Therapy Product Offered
11.14.3 EmCell Cardiac Disease Stem Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 EmCell Main Business Overview
11.14.5 EmCell Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Cardiac Disease Stem Cell Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Cardiac Disease Stem Cell Therapy Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Autologous
Table 4. Major Players of Allogeneic
Table 5. Cardiac Disease Stem Cell Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Cardiac Disease Stem Cell Therapy Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Cardiac Disease Stem Cell Therapy Market Size Market Share by Type (2021-2026)
Table 8. Cardiac Disease Stem Cell Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Cardiac Disease Stem Cell Therapy Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Cardiac Disease Stem Cell Therapy Market Size Market Share by Application (2021-2026)
Table 11. Global Cardiac Disease Stem Cell Therapy Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Cardiac Disease Stem Cell Therapy Revenue Market Share by Player (2021-2026)
Table 13. Cardiac Disease Stem Cell Therapy Key Players Head office and Products Offered
Table 14. Cardiac Disease Stem Cell Therapy Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Cardiac Disease Stem Cell Therapy Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Cardiac Disease Stem Cell Therapy Market Size Market Share by Region (2021-2026)
Table 19. Global Cardiac Disease Stem Cell Therapy Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Cardiac Disease Stem Cell Therapy Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Cardiac Disease Stem Cell Therapy Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Cardiac Disease Stem Cell Therapy Market Size Market Share by Country (2021-2026)
Table 23. Americas Cardiac Disease Stem Cell Therapy Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Cardiac Disease Stem Cell Therapy Market Size Market Share by Type (2021-2026)
Table 25. Americas Cardiac Disease Stem Cell Therapy Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Cardiac Disease Stem Cell Therapy Market Size Market Share by Application (2021-2026)
Table 27. APAC Cardiac Disease Stem Cell Therapy Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Cardiac Disease Stem Cell Therapy Market Size Market Share by Region (2021-2026)
Table 29. APAC Cardiac Disease Stem Cell Therapy Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Cardiac Disease Stem Cell Therapy Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Cardiac Disease Stem Cell Therapy Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Cardiac Disease Stem Cell Therapy Market Size Market Share by Country (2021-2026)
Table 33. Europe Cardiac Disease Stem Cell Therapy Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Cardiac Disease Stem Cell Therapy Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Cardiac Disease Stem Cell Therapy Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Cardiac Disease Stem Cell Therapy Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Cardiac Disease Stem Cell Therapy Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Cardiac Disease Stem Cell Therapy
Table 39. Key Market Challenges & Risks of Cardiac Disease Stem Cell Therapy
Table 40. Key Industry Trends of Cardiac Disease Stem Cell Therapy
Table 41. Global Cardiac Disease Stem Cell Therapy Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Cardiac Disease Stem Cell Therapy Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Cardiac Disease Stem Cell Therapy Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Cardiac Disease Stem Cell Therapy Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Pharmicell Details, Company Type, Cardiac Disease Stem Cell Therapy Area Served and Its Competitors
Table 46. Pharmicell Cardiac Disease Stem Cell Therapy Product Offered
Table 47. Pharmicell Cardiac Disease Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Pharmicell Main Business
Table 49. Pharmicell Latest Developments
Table 50. Gencell Details, Company Type, Cardiac Disease Stem Cell Therapy Area Served and Its Competitors
Table 51. Gencell Cardiac Disease Stem Cell Therapy Product Offered
Table 52. Gencell Cardiac Disease Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Gencell Main Business
Table 54. Gencell Latest Developments
Table 55. BlueRock Therapeutics Details, Company Type, Cardiac Disease Stem Cell Therapy Area Served and Its Competitors
Table 56. BlueRock Therapeutics Cardiac Disease Stem Cell Therapy Product Offered
Table 57. BlueRock Therapeutics Cardiac Disease Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. BlueRock Therapeutics Main Business
Table 59. BlueRock Therapeutics Latest Developments
Table 60. Cellino Biotech Details, Company Type, Cardiac Disease Stem Cell Therapy Area Served and Its Competitors
Table 61. Cellino Biotech Cardiac Disease Stem Cell Therapy Product Offered
Table 62. Cellino Biotech Cardiac Disease Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Cellino Biotech Main Business
Table 64. Cellino Biotech Latest Developments
Table 65. Mesoblast Details, Company Type, Cardiac Disease Stem Cell Therapy Area Served and Its Competitors
Table 66. Mesoblast Cardiac Disease Stem Cell Therapy Product Offered
Table 67. Mesoblast Cardiac Disease Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Mesoblast Main Business
Table 69. Mesoblast Latest Developments
Table 70. BioCardia Details, Company Type, Cardiac Disease Stem Cell Therapy Area Served and Its Competitors
Table 71. BioCardia Cardiac Disease Stem Cell Therapy Product Offered
Table 72. BioCardia Cardiac Disease Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. BioCardia Main Business
Table 74. BioCardia Latest Developments
Table 75. Cedars-Sinai Details, Company Type, Cardiac Disease Stem Cell Therapy Area Served and Its Competitors
Table 76. Cedars-Sinai Cardiac Disease Stem Cell Therapy Product Offered
Table 77. Cedars-Sinai Cardiac Disease Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Cedars-Sinai Main Business
Table 79. Cedars-Sinai Latest Developments
Table 80. Stem Cells Transplant Institute Details, Company Type, Cardiac Disease Stem Cell Therapy Area Served and Its Competitors
Table 81. Stem Cells Transplant Institute Cardiac Disease Stem Cell Therapy Product Offered
Table 82. Stem Cells Transplant Institute Cardiac Disease Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Stem Cells Transplant Institute Main Business
Table 84. Stem Cells Transplant Institute Latest Developments
Table 85. CCTRN Details, Company Type, Cardiac Disease Stem Cell Therapy Area Served and Its Competitors
Table 86. CCTRN Cardiac Disease Stem Cell Therapy Product Offered
Table 87. CCTRN Cardiac Disease Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. CCTRN Main Business
Table 89. CCTRN Latest Developments
Table 90. Help Therapeutics Co., Ltd. Details, Company Type, Cardiac Disease Stem Cell Therapy Area Served and Its Competitors
Table 91. Help Therapeutics Co., Ltd. Cardiac Disease Stem Cell Therapy Product Offered
Table 92. Help Therapeutics Co., Ltd. Cardiac Disease Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Help Therapeutics Co., Ltd. Main Business
Table 94. Help Therapeutics Co., Ltd. Latest Developments
Table 95. Beijing Cellapy biotechnology Co., LTD Details, Company Type, Cardiac Disease Stem Cell Therapy Area Served and Its Competitors
Table 96. Beijing Cellapy biotechnology Co., LTD Cardiac Disease Stem Cell Therapy Product Offered
Table 97. Beijing Cellapy biotechnology Co., LTD Cardiac Disease Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Beijing Cellapy biotechnology Co., LTD Main Business
Table 99. Beijing Cellapy biotechnology Co., LTD Latest Developments
Table 100. CardioCell Details, Company Type, Cardiac Disease Stem Cell Therapy Area Served and Its Competitors
Table 101. CardioCell Cardiac Disease Stem Cell Therapy Product Offered
Table 102. CardioCell Cardiac Disease Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. CardioCell Main Business
Table 104. CardioCell Latest Developments
Table 105. Heartseed Details, Company Type, Cardiac Disease Stem Cell Therapy Area Served and Its Competitors
Table 106. Heartseed Cardiac Disease Stem Cell Therapy Product Offered
Table 107. Heartseed Cardiac Disease Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Heartseed Main Business
Table 109. Heartseed Latest Developments
Table 110. EmCell Details, Company Type, Cardiac Disease Stem Cell Therapy Area Served and Its Competitors
Table 111. EmCell Cardiac Disease Stem Cell Therapy Product Offered
Table 112. EmCell Cardiac Disease Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. EmCell Main Business
Table 114. EmCell Latest Developments
Table 1. Cardiac Disease Stem Cell Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Cardiac Disease Stem Cell Therapy Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Autologous
Table 4. Major Players of Allogeneic
Table 5. Cardiac Disease Stem Cell Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Cardiac Disease Stem Cell Therapy Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Cardiac Disease Stem Cell Therapy Market Size Market Share by Type (2021-2026)
Table 8. Cardiac Disease Stem Cell Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Cardiac Disease Stem Cell Therapy Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Cardiac Disease Stem Cell Therapy Market Size Market Share by Application (2021-2026)
Table 11. Global Cardiac Disease Stem Cell Therapy Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Cardiac Disease Stem Cell Therapy Revenue Market Share by Player (2021-2026)
Table 13. Cardiac Disease Stem Cell Therapy Key Players Head office and Products Offered
Table 14. Cardiac Disease Stem Cell Therapy Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Cardiac Disease Stem Cell Therapy Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Cardiac Disease Stem Cell Therapy Market Size Market Share by Region (2021-2026)
Table 19. Global Cardiac Disease Stem Cell Therapy Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Cardiac Disease Stem Cell Therapy Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Cardiac Disease Stem Cell Therapy Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Cardiac Disease Stem Cell Therapy Market Size Market Share by Country (2021-2026)
Table 23. Americas Cardiac Disease Stem Cell Therapy Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Cardiac Disease Stem Cell Therapy Market Size Market Share by Type (2021-2026)
Table 25. Americas Cardiac Disease Stem Cell Therapy Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Cardiac Disease Stem Cell Therapy Market Size Market Share by Application (2021-2026)
Table 27. APAC Cardiac Disease Stem Cell Therapy Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Cardiac Disease Stem Cell Therapy Market Size Market Share by Region (2021-2026)
Table 29. APAC Cardiac Disease Stem Cell Therapy Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Cardiac Disease Stem Cell Therapy Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Cardiac Disease Stem Cell Therapy Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Cardiac Disease Stem Cell Therapy Market Size Market Share by Country (2021-2026)
Table 33. Europe Cardiac Disease Stem Cell Therapy Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Cardiac Disease Stem Cell Therapy Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Cardiac Disease Stem Cell Therapy Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Cardiac Disease Stem Cell Therapy Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Cardiac Disease Stem Cell Therapy Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Cardiac Disease Stem Cell Therapy
Table 39. Key Market Challenges & Risks of Cardiac Disease Stem Cell Therapy
Table 40. Key Industry Trends of Cardiac Disease Stem Cell Therapy
Table 41. Global Cardiac Disease Stem Cell Therapy Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Cardiac Disease Stem Cell Therapy Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Cardiac Disease Stem Cell Therapy Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Cardiac Disease Stem Cell Therapy Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Pharmicell Details, Company Type, Cardiac Disease Stem Cell Therapy Area Served and Its Competitors
Table 46. Pharmicell Cardiac Disease Stem Cell Therapy Product Offered
Table 47. Pharmicell Cardiac Disease Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Pharmicell Main Business
Table 49. Pharmicell Latest Developments
Table 50. Gencell Details, Company Type, Cardiac Disease Stem Cell Therapy Area Served and Its Competitors
Table 51. Gencell Cardiac Disease Stem Cell Therapy Product Offered
Table 52. Gencell Cardiac Disease Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Gencell Main Business
Table 54. Gencell Latest Developments
Table 55. BlueRock Therapeutics Details, Company Type, Cardiac Disease Stem Cell Therapy Area Served and Its Competitors
Table 56. BlueRock Therapeutics Cardiac Disease Stem Cell Therapy Product Offered
Table 57. BlueRock Therapeutics Cardiac Disease Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. BlueRock Therapeutics Main Business
Table 59. BlueRock Therapeutics Latest Developments
Table 60. Cellino Biotech Details, Company Type, Cardiac Disease Stem Cell Therapy Area Served and Its Competitors
Table 61. Cellino Biotech Cardiac Disease Stem Cell Therapy Product Offered
Table 62. Cellino Biotech Cardiac Disease Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Cellino Biotech Main Business
Table 64. Cellino Biotech Latest Developments
Table 65. Mesoblast Details, Company Type, Cardiac Disease Stem Cell Therapy Area Served and Its Competitors
Table 66. Mesoblast Cardiac Disease Stem Cell Therapy Product Offered
Table 67. Mesoblast Cardiac Disease Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Mesoblast Main Business
Table 69. Mesoblast Latest Developments
Table 70. BioCardia Details, Company Type, Cardiac Disease Stem Cell Therapy Area Served and Its Competitors
Table 71. BioCardia Cardiac Disease Stem Cell Therapy Product Offered
Table 72. BioCardia Cardiac Disease Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. BioCardia Main Business
Table 74. BioCardia Latest Developments
Table 75. Cedars-Sinai Details, Company Type, Cardiac Disease Stem Cell Therapy Area Served and Its Competitors
Table 76. Cedars-Sinai Cardiac Disease Stem Cell Therapy Product Offered
Table 77. Cedars-Sinai Cardiac Disease Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Cedars-Sinai Main Business
Table 79. Cedars-Sinai Latest Developments
Table 80. Stem Cells Transplant Institute Details, Company Type, Cardiac Disease Stem Cell Therapy Area Served and Its Competitors
Table 81. Stem Cells Transplant Institute Cardiac Disease Stem Cell Therapy Product Offered
Table 82. Stem Cells Transplant Institute Cardiac Disease Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Stem Cells Transplant Institute Main Business
Table 84. Stem Cells Transplant Institute Latest Developments
Table 85. CCTRN Details, Company Type, Cardiac Disease Stem Cell Therapy Area Served and Its Competitors
Table 86. CCTRN Cardiac Disease Stem Cell Therapy Product Offered
Table 87. CCTRN Cardiac Disease Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. CCTRN Main Business
Table 89. CCTRN Latest Developments
Table 90. Help Therapeutics Co., Ltd. Details, Company Type, Cardiac Disease Stem Cell Therapy Area Served and Its Competitors
Table 91. Help Therapeutics Co., Ltd. Cardiac Disease Stem Cell Therapy Product Offered
Table 92. Help Therapeutics Co., Ltd. Cardiac Disease Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Help Therapeutics Co., Ltd. Main Business
Table 94. Help Therapeutics Co., Ltd. Latest Developments
Table 95. Beijing Cellapy biotechnology Co., LTD Details, Company Type, Cardiac Disease Stem Cell Therapy Area Served and Its Competitors
Table 96. Beijing Cellapy biotechnology Co., LTD Cardiac Disease Stem Cell Therapy Product Offered
Table 97. Beijing Cellapy biotechnology Co., LTD Cardiac Disease Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Beijing Cellapy biotechnology Co., LTD Main Business
Table 99. Beijing Cellapy biotechnology Co., LTD Latest Developments
Table 100. CardioCell Details, Company Type, Cardiac Disease Stem Cell Therapy Area Served and Its Competitors
Table 101. CardioCell Cardiac Disease Stem Cell Therapy Product Offered
Table 102. CardioCell Cardiac Disease Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. CardioCell Main Business
Table 104. CardioCell Latest Developments
Table 105. Heartseed Details, Company Type, Cardiac Disease Stem Cell Therapy Area Served and Its Competitors
Table 106. Heartseed Cardiac Disease Stem Cell Therapy Product Offered
Table 107. Heartseed Cardiac Disease Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Heartseed Main Business
Table 109. Heartseed Latest Developments
Table 110. EmCell Details, Company Type, Cardiac Disease Stem Cell Therapy Area Served and Its Competitors
Table 111. EmCell Cardiac Disease Stem Cell Therapy Product Offered
Table 112. EmCell Cardiac Disease Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. EmCell Main Business
Table 114. EmCell Latest Developments
LIST OF FIGURES
Figure 1. Cardiac Disease Stem Cell Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cardiac Disease Stem Cell Therapy Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Cardiac Disease Stem Cell Therapy Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Cardiac Disease Stem Cell Therapy Sales Market Share by Country/Region (2025)
Figure 8. Cardiac Disease Stem Cell Therapy Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Cardiac Disease Stem Cell Therapy Market Size Market Share by Type in 2025
Figure 10. Cardiac Disease Stem Cell Therapy in Preclinical
Figure 11. Global Cardiac Disease Stem Cell Therapy Market: Preclinical (2021-2026) & ($ millions)
Figure 12. Cardiac Disease Stem Cell Therapy in Clinical Phase 1,2
Figure 13. Global Cardiac Disease Stem Cell Therapy Market: Clinical Phase 1,2 (2021-2026) & ($ millions)
Figure 14. Global Cardiac Disease Stem Cell Therapy Market Size Market Share by Application in 2025
Figure 15. Global Cardiac Disease Stem Cell Therapy Revenue Market Share by Player in 2025
Figure 16. Global Cardiac Disease Stem Cell Therapy Market Size Market Share by Region (2021-2026)
Figure 17. Americas Cardiac Disease Stem Cell Therapy Market Size 2021-2026 ($ millions)
Figure 18. APAC Cardiac Disease Stem Cell Therapy Market Size 2021-2026 ($ millions)
Figure 19. Europe Cardiac Disease Stem Cell Therapy Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa Cardiac Disease Stem Cell Therapy Market Size 2021-2026 ($ millions)
Figure 21. Americas Cardiac Disease Stem Cell Therapy Value Market Share by Country in 2025
Figure 22. United States Cardiac Disease Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada Cardiac Disease Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico Cardiac Disease Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil Cardiac Disease Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC Cardiac Disease Stem Cell Therapy Market Size Market Share by Region in 2025
Figure 27. APAC Cardiac Disease Stem Cell Therapy Market Size Market Share by Type (2021-2026)
Figure 28. APAC Cardiac Disease Stem Cell Therapy Market Size Market Share by Application (2021-2026)
Figure 29. China Cardiac Disease Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan Cardiac Disease Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea Cardiac Disease Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia Cardiac Disease Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 33. India Cardiac Disease Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia Cardiac Disease Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe Cardiac Disease Stem Cell Therapy Market Size Market Share by Country in 2025
Figure 36. Europe Cardiac Disease Stem Cell Therapy Market Size Market Share by Type (2021-2026)
Figure 37. Europe Cardiac Disease Stem Cell Therapy Market Size Market Share by Application (2021-2026)
Figure 38. Germany Cardiac Disease Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 39. France Cardiac Disease Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 40. UK Cardiac Disease Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy Cardiac Disease Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia Cardiac Disease Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa Cardiac Disease Stem Cell Therapy Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa Cardiac Disease Stem Cell Therapy Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa Cardiac Disease Stem Cell Therapy Market Size Market Share by Application (2021-2026)
Figure 46. Egypt Cardiac Disease Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa Cardiac Disease Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel Cardiac Disease Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey Cardiac Disease Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries Cardiac Disease Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas Cardiac Disease Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 52. APAC Cardiac Disease Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 53. Europe Cardiac Disease Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa Cardiac Disease Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 55. United States Cardiac Disease Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 56. Canada Cardiac Disease Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 57. Mexico Cardiac Disease Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 58. Brazil Cardiac Disease Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 59. China Cardiac Disease Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 60. Japan Cardiac Disease Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 61. Korea Cardiac Disease Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia Cardiac Disease Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 63. India Cardiac Disease Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 64. Australia Cardiac Disease Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 65. Germany Cardiac Disease Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 66. France Cardiac Disease Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 67. UK Cardiac Disease Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 68. Italy Cardiac Disease Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 69. Russia Cardiac Disease Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 70. Egypt Cardiac Disease Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 71. South Africa Cardiac Disease Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 72. Israel Cardiac Disease Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 73. Turkey Cardiac Disease Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 74. Global Cardiac Disease Stem Cell Therapy Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global Cardiac Disease Stem Cell Therapy Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries Cardiac Disease Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 1. Cardiac Disease Stem Cell Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cardiac Disease Stem Cell Therapy Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Cardiac Disease Stem Cell Therapy Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Cardiac Disease Stem Cell Therapy Sales Market Share by Country/Region (2025)
Figure 8. Cardiac Disease Stem Cell Therapy Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Cardiac Disease Stem Cell Therapy Market Size Market Share by Type in 2025
Figure 10. Cardiac Disease Stem Cell Therapy in Preclinical
Figure 11. Global Cardiac Disease Stem Cell Therapy Market: Preclinical (2021-2026) & ($ millions)
Figure 12. Cardiac Disease Stem Cell Therapy in Clinical Phase 1,2
Figure 13. Global Cardiac Disease Stem Cell Therapy Market: Clinical Phase 1,2 (2021-2026) & ($ millions)
Figure 14. Global Cardiac Disease Stem Cell Therapy Market Size Market Share by Application in 2025
Figure 15. Global Cardiac Disease Stem Cell Therapy Revenue Market Share by Player in 2025
Figure 16. Global Cardiac Disease Stem Cell Therapy Market Size Market Share by Region (2021-2026)
Figure 17. Americas Cardiac Disease Stem Cell Therapy Market Size 2021-2026 ($ millions)
Figure 18. APAC Cardiac Disease Stem Cell Therapy Market Size 2021-2026 ($ millions)
Figure 19. Europe Cardiac Disease Stem Cell Therapy Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa Cardiac Disease Stem Cell Therapy Market Size 2021-2026 ($ millions)
Figure 21. Americas Cardiac Disease Stem Cell Therapy Value Market Share by Country in 2025
Figure 22. United States Cardiac Disease Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada Cardiac Disease Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico Cardiac Disease Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil Cardiac Disease Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC Cardiac Disease Stem Cell Therapy Market Size Market Share by Region in 2025
Figure 27. APAC Cardiac Disease Stem Cell Therapy Market Size Market Share by Type (2021-2026)
Figure 28. APAC Cardiac Disease Stem Cell Therapy Market Size Market Share by Application (2021-2026)
Figure 29. China Cardiac Disease Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan Cardiac Disease Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea Cardiac Disease Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia Cardiac Disease Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 33. India Cardiac Disease Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia Cardiac Disease Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe Cardiac Disease Stem Cell Therapy Market Size Market Share by Country in 2025
Figure 36. Europe Cardiac Disease Stem Cell Therapy Market Size Market Share by Type (2021-2026)
Figure 37. Europe Cardiac Disease Stem Cell Therapy Market Size Market Share by Application (2021-2026)
Figure 38. Germany Cardiac Disease Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 39. France Cardiac Disease Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 40. UK Cardiac Disease Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy Cardiac Disease Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia Cardiac Disease Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa Cardiac Disease Stem Cell Therapy Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa Cardiac Disease Stem Cell Therapy Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa Cardiac Disease Stem Cell Therapy Market Size Market Share by Application (2021-2026)
Figure 46. Egypt Cardiac Disease Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa Cardiac Disease Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel Cardiac Disease Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey Cardiac Disease Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries Cardiac Disease Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas Cardiac Disease Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 52. APAC Cardiac Disease Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 53. Europe Cardiac Disease Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa Cardiac Disease Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 55. United States Cardiac Disease Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 56. Canada Cardiac Disease Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 57. Mexico Cardiac Disease Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 58. Brazil Cardiac Disease Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 59. China Cardiac Disease Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 60. Japan Cardiac Disease Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 61. Korea Cardiac Disease Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia Cardiac Disease Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 63. India Cardiac Disease Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 64. Australia Cardiac Disease Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 65. Germany Cardiac Disease Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 66. France Cardiac Disease Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 67. UK Cardiac Disease Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 68. Italy Cardiac Disease Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 69. Russia Cardiac Disease Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 70. Egypt Cardiac Disease Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 71. South Africa Cardiac Disease Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 72. Israel Cardiac Disease Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 73. Turkey Cardiac Disease Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 74. Global Cardiac Disease Stem Cell Therapy Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global Cardiac Disease Stem Cell Therapy Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries Cardiac Disease Stem Cell Therapy Market Size 2027-2032 ($ millions)
